Seach Medical Group Ltd Cash Flow Conversion Efficiency
Seach Medical Group Ltd cash flow conversion efficiency. Based on the latest financial reports, Seach Medical Group Ltd (SEMG) has a cash flow conversion efficiency ratio of 0.082x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA8.42 Million ≈ $22.57K USD) by net assets (ILA103.11 Million ≈ $276.45K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Seach Medical Group Ltd (2015–2025)
Cash flow conversion efficiency of Seach Medical Group Ltd from 2015 to 2025. This chart illustrates how Seach Medical Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SEMG stock price and chart for real-time trading data and today's change.
Seach Medical Group Ltd Cash Flow Conversion Ratio Explained
Seach Medical Group Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Seach Medical Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seach Medical Group Ltd ranked by their cash flow conversion efficiency. Also see how much is Seach Medical Group Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dunelm Group PLC
LSE:DNLM
|
0.128x |
|
Newtree Co.Ltd
KQ:270870
|
-0.007x |
|
Data I/O Corporation
NASDAQ:DAIO
|
-0.025x |
|
CrystalGenomics Inc
KQ:083790
|
-0.129x |
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
-0.136x |
|
Accent Resources NL
AU:ACS
|
-0.036x |
|
Petratherm Ltd
AU:PTR
|
-0.044x |
|
Lider Faktoring AS
IS:LIDFA
|
-0.140x |
Annual Cash Flow Conversion Efficiency for Seach Medical Group Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Seach Medical Group Ltd from 2015 to 2025. Review free cash flow generation of Seach Medical Group Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA99.53 Million ≈ $266.84K |
ILA16.61 Million ≈ $44.52K |
0.167x | +5.45% |
| 2024-12-31 | ILA102.94 Million ≈ $275.97K |
ILA16.29 Million ≈ $43.66K |
0.158x | +6158.10% |
| 2023-12-31 | ILA88.99 Million ≈ $238.58K |
ILA225.00K ≈ $603.22 |
0.003x | -98.52% |
| 2022-12-31 | ILA101.62 Million ≈ $272.43K |
ILA17.39 Million ≈ $46.63K |
0.171x | +301.28% |
| 2021-12-31 | ILA95.58 Million ≈ $256.24K |
ILA-8.13 Million ≈ $-21.79K |
-0.085x | -17.17% |
| 2020-12-31 | ILA79.25 Million ≈ $212.47K |
ILA-5.75 Million ≈ $-15.42K |
-0.073x | -509.90% |
| 2019-12-31 | ILA46.76 Million ≈ $125.36K |
ILA828.00K ≈ $2.22K |
0.018x | -87.73% |
| 2018-12-31 | ILA25.69 Million ≈ $68.87K |
ILA3.71 Million ≈ $9.94K |
0.144x | +155.80% |
| 2017-12-31 | ILA31.38 Million ≈ $84.12K |
ILA1.77 Million ≈ $4.75K |
0.056x | +132.72% |
| 2016-12-31 | ILA-3.64 Million ≈ $-9.75K |
ILA627.00K ≈ $1.68K |
-0.172x | -101.97% |
| 2015-12-31 | ILA-362.00K ≈ $-970.51 |
ILA-3.17 Million ≈ $-8.49K |
8.749x | -- |
About Seach Medical Group Ltd
Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company provides cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was incorporated in 1987 and is based in Ramat Gan, Israel.